Nu-Med Plus Inc (NUMD)
OTHER OTC:NUMD
US Market

Nu-Med Plus (NUMD) Technical Analysis

2 Followers

Summary of all the Indicators

Overall Consensus
Buy
10Bullish
5Neutral
6Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
0Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Nu-Med Plus Inc’s (NUMD) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Nu-Med Plus Inc is a Buy.
Nu-Med Plus Inc’s (NUMD) 20-Day exponential moving average is 0.06, while Nu-Med Plus Inc’s (NUMD) share price is <$0.1, making it a Sell.
Nu-Med Plus Inc’s (NUMD) 50-Day exponential moving average is 0.06, while Nu-Med Plus Inc’s (NUMD) share price is <$0.1, making it a Buy.

Nu-Med Plus (NUMD) Pivot Points

Jul 24, 2024, 02:17 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.06
0.07
0.07
0.07
0.07
0.07
0.08
Fibonacci
0.07
0.07
0.07
0.07
0.07
0.07
0.07
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Nu-Med Plus (NUMD) Moving Averages

Jul 24, 2024, 02:17 PM
Period
Simple
Exponential
MA5
0.06Sell
0.06Sell
MA10
0.06Sell
0.06Sell
MA20
0.06Sell
0.06Sell
MA50
0.06Buy
0.06Buy
MA100
0.06Buy
0.05Buy
MA200
0.04Buy
0.04Buy
Nu-Med Plus Inc’s (NUMD) 10-Day exponential moving average is 0.06, while Nu-Med Plus Inc’s (NUMD) share price is <$0.1, making it a Sell.
Nu-Med Plus Inc’s (NUMD) 100-Day exponential moving average is 0.05, while Nu-Med Plus Inc’s (NUMD) share price is <$0.1, making it a Buy.
Nu-Med Plus Inc’s (NUMD) stock price is <$0.1 and Nu-Med Plus Inc’s (NUMD) 50-day simple moving average is 0.06, creating a Buy signal.
Nu-Med Plus Inc’s (NUMD) stock price is <$0.1 and Nu-Med Plus Inc’s (NUMD) 100-day simple moving average is 0.06, creating a Buy signal.
Nu-Med Plus Inc’s (NUMD) stock price is <$0.1 and Nu-Med Plus Inc’s (NUMD) 200-day simple moving average is 0.04, creating a Buy signal.

Nu-Med Plus (NUMD) Technical Indicators

Jul 24, 2024, 02:17 PM
Name
Value
Implied Action
RSI (14)
49.30
Neutral
STOCH (9,6)
46.30
Neutral
STOCHRSI (14)
46.30
Neutral
MACD (12,26)
<0.01
Buy
ADX (14)
12.29
Buy
Williams %R
-72.22
Buy
CCI (14)
-27.14
Neutral
ATR (14)
0.01
-
Ultimate Oscillator
45.82
Neutral
ROC
0.00
-
Nu-Med Plus Inc’s (NUMD) Relative Strength Index (RSI) is 49.30, creating a Neutral signal.
Nu-Med Plus Inc’s (NUMD) Trend Strength Indicator (ADX) is 12.29, creating a Buy signal.
Nu-Med Plus Inc’s (NUMD) Commodity Channel Index (CCI) is -27.14, creating a Neutral signal.

FAQ

Is NUMD a Buy, Hold, or Sell?
Based on NUMD’s technical indicators, NUMD is a Buy.
    What is NUMD’s RSI (14)?
    NUMD’s RSI (14) is 49.30, which suggests NUMD is a Neutral.
      What is NUMD’s MACD?
      NUMD’s MACD is <0.01, which suggests NUMD is a Buy.
        What is NUMD’s 5-day moving average?
        NUMD’s 5-day moving average is 0.06, which suggests NUMD is a Sell.
          What is NUMD’s 20-day moving average?
          NUMD 20-day moving average is 0.06, which suggests NUMD is a Sell.
            What is NUMD’s 50-day moving average?
            NUMD’s 50-day moving average is 0.06, which suggests NUMD is a Buy.
              What is NUMD’s 200-day moving average?
              NUMD’s 200-day moving average is 0.04, which suggests NUMD is a Buy.
                What is NUMD’s Williams % R (14)?
                NUMD’s Williams % R (14) is -72.22, which suggests NUMD is a Buy.
                  What is NUMD’s CCI (14)?
                  NUMD’s CCI (14) is -27.14, which suggests NUMD is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis